Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The primary objective of the trial is to evaluate the efficacy of early invasive strategy for STEMI patients within 24-48h of symptom onset.
Epistemonikos ID: 3b7b3ebf9c491c5e5fbc16ab8c3731bc4e345ec3
First added on: May 09, 2024